Nutex Health (NUTX) Change in Receivables (2011 - 2026)

Nutex Health (NUTX) has 16 years of Change in Receivables data on file, last reported at $20.1 million in Q1 2026.

• Quarterly Change in Receivables rose 2967.07% year-over-year to $20.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.8 million (down 87.49% YoY) and the FY2025 annual result came in at $2.4 million, down 98.63% from the prior year.
• Change in Receivables climbed to $20.1 million in Q1 2026 per NUTX's latest filing, from -$152.6 million in the prior quarter.
• The five-year high for Change in Receivables was $169.7 million in Q4 2024, with the low at -$152.6 million in Q4 2025.
• Average Change in Receivables over 5 years is $8.4 million, with a median of $656000.0 recorded in 2025.
• Year-over-year, Change in Receivables plunged 30079.22% in 2022 and surged 61900.0% in 2024.
• Nutex Health's Change in Receivables stood at -$54.8 million in 2022, then surged by 104.86% to $2.7 million in 2023, then surged by 6268.85% to $169.7 million in 2024, then slumped by 189.91% to -$152.6 million in 2025, then surged by 113.19% to $20.1 million in 2026.
• Business Quant data shows NUTX's Change in Receivables at $20.1 million in Q1 2026, -$152.6 million in Q4 2025, and $152.8 million in Q3 2025.